Euroopa Liit - eesti - EMA (European Medicines Agency)

koanaa healthcare gmbh - imatinib mesilate - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma; gastrointestinal stromal tumors - antineoplastilised ained - imatinib koanaa is indicated for the treatment ofadult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph+ all as monotherapy. adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement. the effect of imatinib on the outcome of bone marrow transplantation has not been determined. imatinib koanaa is indicated forthe treatment of adult patients with kit (cd 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patsientidel, kellel on madal või väga madal risk kordumise ei tohiks saada abiaine ravi. the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic gist and dfsp and on recurrence-free survival in adjuvant gist. the experience with imatinib in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5. välja arvatud äsja diagnoositud kroonilise faasi cml, ei ole kontrollitud uuringud, mis näitab kliiniline kasu või suurenenud ellujäämise eest need haigused.

Eesti - eesti - Ravimiamet

koanaa healthcare gmbh - pemetrekseed - infusioonilahuse kontsentraadi pulber - 500mg 1tk

Eesti - eesti - Ravimiamet

koanaa healthcare gmbh - pemetrekseed - infusioonilahuse kontsentraadi pulber - 100mg 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

laboratorios hipra, s.a. - vaktsiin kanade eest koktsidioosi vastu - live parasiitide vaktsiinid, immunoloogilised ravimid jaoks aves - kana - aktiivse immuniseerimise tibude alates 1. päeval vanuse, et vähendada kliinilisi tunnuseid (kõhulahtisus), seedetrakti kahjustused ja ootsüsti väljund seotud coccidiosis põhjustatud eimeria acervulina, eimeria brunetti, eimeria maxima, eimeria necatrix ja eimeria tenella.

Euroopa Liit - eesti - EMA (European Medicines Agency)

zoetis belgium sa - elav aroa geen kustutati escherichia coli, tüüp 078, tüvi ec34195 - immunoloogilised ravimid jaoks linnud, live bacterial vaccines - chicken; turkeys - aktiivse immuniseerimise kohta lihakanade ja tulevikus kihid / kasvatajad, et vähendada suremust ja kahjustused (perikardiit, perihepatitis, airsacculitis) seotud escherichia coli (serotüüp o78.

Eesti - eesti - Ravimiamet

accord healthcare b.v. - rasagiliin - tablett - 1mg 28tk; 1mg 112tk; 1mg 100tk; 1mg 60tk; 1mg 10tk; 1mg 56tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - pregabaliin - kõvakapsel - 200mg 21tk; 200mg 90tk; 200mg 30tk; 200mg 100tk; 200mg 112tk; 200mg 84tk; 200mg 200tk; 200mg 14tk; 200mg 60tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - pregabaliin - kõvakapsel - 50mg 21tk; 50mg 100tk; 50mg 60tk; 50mg 84tk; 50mg 56tk; 50mg 14tk; 50mg 200tk; 50mg 90tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - pregabaliin - kõvakapsel - 100mg 56tk; 100mg 30tk; 100mg 90tk; 100mg 112tk; 100mg 84tk; 100mg 60tk; 100mg 21tk; 100mg 200tk; 100mg 14tk; 100mg 100tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - pregabaliin - kõvakapsel - 300mg 100tk; 300mg 56tk; 300mg 112tk; 300mg 14tk; 300mg 200tk; 300mg 30tk; 300mg 60tk; 300mg 90tk